Analysis of clinical data of anti-dipeptidyl peptidase-like protein 6 encephalitis
Journal Title: Chinese Journal of Nervous and Mental Diseases - Year 2024, Vol 50, Issue 3
Abstract
[Objective] We analyzed clinical characteristics of dipeptidyl-peptidase-like protein 6 (DPPX) antibody-associated encephalitis and evaluated the effect of immunotherapy on anti-DPPX encephalitis. [Methods] A total of 9 patients with anti-DPPX encephalitis were retrospectively analyzed, including clinical manifestations, laboratory examinations, imaging features, treatment and prognosis. [Results] Nine patients were identified (medium age 45 years old, 5 were men). Neurologic disorders were multifocal: cognitive dysfunction (3 cases), psychosis (anxiety, irritability, auditory hallucination, abnormal behavior) (3 cases), CNS hyperexcitability (6 cases), brainstem (5 cases), cerebellar dysfunction (4 cases), sleep disorders (3 cases), dysautonomia (1 case), allodynia (1 case). In additional, there were 4 patients complicated with weight loss and/or gastrointestinal symptoms. CSF data showed that white cell counts were elevated in 2 patients and protein levels were elevated in 4 patients. EEG revealed epileptiform discharges in 3 patients and delta wave in 1 patient. Abnormalities were found in the brain MRIs of 4 patients including T2/FLAIR lesions in the hippocampus, insula. Seven patients received corticosteroids and six patients received plasma exchange. Seven patients subsequently treated with Mycophenolate Mofetil. Among 7 patients with adequate follow-up data, all patients had recovered to some degree and 3 of them completely remitted after 4 months to 2 years of follow-up. [Conclusion] The clinical symptoms of anti-DPPX encephalitis were diverse, the classic triad of clinical symptoms were weight loss and/or gastrointestinal disorders, CNS hyperexcitability and cognitive disorders. Long-term oral Mycophenolate Mofetil may be helpful in improving prognosis and reducing recurrence.
Authors and Affiliations
Genxia HE, Junchao. QIAN
Analysis of clinical data of anti-dipeptidyl peptidase-like protein 6 encephalitis
[Objective] We analyzed clinical characteristics of dipeptidyl-peptidase-like protein 6 (DPPX) antibody-associated encephalitis and evaluated the effect of immunotherapy on anti-DPPX encephalitis. [Methods] A total of 9...
Cerebellar symptoms and imaging features in neurodegenerative diseases
Pathological, electrophysiological, and neuroimaging changes in the cerebellum can occur in neurodegenerative diseases such as Alzheimer disease, Parkinson disease, and amyotrophic lateral sclerosis. The activation and n...
A case-control study on the attention characteristics of patients with stable schizophrenia
[Objective] To investigate the attention characteristics of patients with stable schizophrenia. [Methods] Fifty-five stable schizophrenic patients and 55 healthy subjects were included in the study. The attention network...
Research progress on the role of proteasome in the pathogenesis of Alzheimer disease
Due to the insufficient understanding of the pathogenesis of Alzheimer disease(AD), investigating the early pathophysiological mechanisms underlying AD is particularly essential for advancing subsequent drug therapies. A...
Research on functional prognosis prediction model of non-cardiac ischemic stroke based on machine learning, thromboelastography and white matter lesions
[Objective] To explore the role and value of thromboelastography (TEG) combined with white matter hyperintensity (WMH) in predicting the functional prognosis of patients with non-cardiogenic acute ischemic stroke (AIS) t...